Ascentage Pharma Group International (OTCMKTS:ASPHF) Sees Significant Growth in Short Interest

Ascentage Pharma Group International (OTCMKTS:ASPHFGet Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 1,550,100 shares, a growth of 80.5% from the December 15th total of 858,900 shares. Based on an average trading volume of 900 shares, the days-to-cover ratio is presently 1,722.3 days.

Ascentage Pharma Group International Price Performance

Shares of Ascentage Pharma Group International stock remained flat at $6.45 during trading on Thursday. Ascentage Pharma Group International has a 1 year low of $6.45 and a 1 year high of $6.45. The firm’s 50-day moving average price is $6.45 and its 200-day moving average price is $4.36.

Ascentage Pharma Group International Company Profile

(Get Free Report)

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.

Read More

Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.